Maxwell Biosciences
Destroys Most Infections with One Nontoxic Molecule. 10 Year FDA Exclusivity on All-Cause Pneumonia.
https://wefunder.com/maxwell.biosciences
Total raised on Wefunder: 351500
Total investors: 32
Quick facts
- FDA QIDP in bacterial & fungal pneumonia: FDA Fast Track, Priority Review, 10-yr exclusivity
- Govt-sponsored primate study: MRSA & Candida cleared from the head in 3 days, no toxicity
- $69M+ in funding & grants; government backing from US, Australia, India, S. Korea & Japan
- 7 signed U.S. military R&D agreements (CRADAs) + a $3M U.S. Army MTEC award, all non-dilutive
- Novel membrane + DNA/RNA mechanism showed no bacterial resistance across 30 lab passages
- Backed by 500+ peer-reviewed published studies; published in-vivo efficacy, safety and no resistance
- A platform, not one drug: AI designs Claromers that mimic the body's own immune peptides
- Board includes Eli Lilly President, Ret. U.S. Army biodefense commanding General, former Congressman